Actively Recruiting
Study on the Clinical Efficacy of Teclistamab
Led by Universitaire Ziekenhuizen KU Leuven · Updated on 2025-03-12
100
Participants Needed
17
Research Sites
143 weeks
Total Duration
On this page
Sponsors
U
Universitaire Ziekenhuizen KU Leuven
Lead Sponsor
J
Janssen Pharmaceutica
Collaborating Sponsor
AI-Summary
What this Trial Is About
The aim of this study is to assess the clinical efficacy and safety of the anti-BCMA/CD3 bispecific antibody teclistamab (Tecvayli®) in a prospective, real-life setting in Belgium.
CONDITIONS
Official Title
Study on the Clinical Efficacy of Teclistamab
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or older
- Written informed consent
- Diagnosis of relapsed and refractory multiple myeloma
- Received at least three previous treatments
- Refractory to at least one proteasome inhibitor, one immunomodulatory agent, and an anti-CD38 monoclonal antibody
- Evidence of disease progression on the last line of therapy based on IMWG response criteria
- Starting teclistamab treatment per routine care or started within 14 days before screening
You will not qualify if you...
- Participation in a teclistamab trial or teclistamab Single Patient Request program
- Started teclistamab treatment more than 14 days before screening
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 17 locations
1
Imelda
Bonheiden, Antwerpen, Belgium, 2820
Not Yet Recruiting
2
Universitair Ziekenhuis Antwerpen (UZA)
Edegem, Antwerpen, Belgium, 2500
Actively Recruiting
3
Grand Hôpital de Charleroi
Charleroi, Henegouwen, Belgium, 6000
Actively Recruiting
4
EpiCURA
Hornu, Henegouwen, Belgium, 7301
Actively Recruiting
5
CHU Ambroise Paré
Mons, Henegouwen, Belgium, 7000
Actively Recruiting
6
Jessa Ziekenhuis
Hasselt, Limburg, Belgium, 3500
Actively Recruiting
7
CHR Citadelle
Liège, Liège, Belgium, 4000
Actively Recruiting
8
CHU Liège
Liège, Liège, Belgium, 4000
Actively Recruiting
9
CHU UCL Namur
Yvoir, Namur, Belgium, 5530
Actively Recruiting
10
Algemeen Ziekenhuis Maria Middelares (AZMM)
Ghent, Oost-Vlaanderen, Belgium, 9000
Actively Recruiting
11
Universitair Ziekenhuis Gent (UZ Gent)
Ghent, Oost-Vlaanderen, Belgium, 9000
Actively Recruiting
12
Vitaz
Sint-Niklaas, Oost-Vlaanderen, Belgium, 9100
Actively Recruiting
13
Institut Jules Bordet
Brussels, Vlaams-Brabant, Belgium, 1070
Actively Recruiting
14
UCL Saint Luc
Brussels, Vlaams-Brabant, Belgium, 1200
Actively Recruiting
15
AZ Groeninge
Kortrijk, West-Vlaanderen, Belgium, 8500
Actively Recruiting
16
AZ Delta
Roeselare, West-Vlaanderen, Belgium, 8800
Actively Recruiting
17
UZ Leuven Gasthuisberg
Leuven, Belgium, 3000
Actively Recruiting
Research Team
M
Michel Delforge, MD, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here